Indegene IPO Subscription Status – IPO Closed

Indegene IPO subscription status started on Monday May 6, 2024 and will close on May 8, 2024. Indegene IPO to raise around ₹1841.76 crores via IPO. The retail quota is 35%, QIB is 50%, and NII is 15%. The price band is fixed at ₹430 to ₹452 per equity share.

Indegene IPO

The Indegene IPO minimum market lot is 33 shares with ₹14,916 application amount. The Indegene IPO is a Mainline IPO, and it is to be listed on BSE and NSE.

Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Their solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient, and modern manner. They achieve this by combining over two decades of healthcare domain expertise and fit-forpurpose technology.


IPOWatch View

We recommend investors may apply for an IPO with Short-term and Long-term Views. Investors should also look at the QIB, NII, and Retail numbers before investing.

Indegene IPO Subscription Status – Day 3

CategoryDay 1Day 2Day 3
QIB0.055.45192.72
NII4.2318.4455.82
bNII4.2419.6762.23
sNII4.2215.9843.01
RII1.543.947.78
Employees1.393.406.57
Total1.697.4470.25


Indegene IPO Investor Categories

  • Qualified Institutional Buyers (QIB): Financial Institutions, Banks, FIIs, and Mutual Funds
  • Non-Institutional Investors(NII): Individual Investors, NRIs, Companies, Trusts, etc
  • Retail Individual Investors (RII): Retail Individual Investors or NRIs
  • Employee (EMP): Eligible Employees
  • Others: Eligible Shareholders

Indegene IPO Review

  • May Apply

Indegene IPO Form

How to apply for the Indegene IPO? You can apply for Indegene IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Indegene IPO in the Invest section. The other option is you can apply for Indegene IPO via IPO forms downloaded online. Check out the Indegene forms – Click IPO Forms blank IPO forms download, fill, and submit in your bank or with your broker.

Indegene IPO Subscription Status FAQs:


When Indegene IPO Subscription will start?

The IPO subscription starts on May 6, 2024 for QIB, NII, and Retail Investors.

How to subscribe Indegene IPO?

You can go with ASBA and Non-ASBA options for a subscription. Go to your bank account and apply for IPO online via ASBA or download the form online or get the physical form and submit the filled form to your broker or bank.

How do I check live Indegene IPO Subscription Numbers Today?

One can visit our portal for live IPO subscription numbers that we are updating hourly basis from the official websites. One can check the live subscription on official websites on the particular IPO page.

How to Apply the Indegene IPO through Zerodha?

Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Indegene “. Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.

How to Apply the Indegene IPO through Upstox?

Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Indegene “. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.

How to Apply the Indegene IPO through Paytm Money?

Log in to Paytm Money Application with your credentials. Select the IPO. You will see the IPO Name “Indegene ” Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Paytm Money.

    Share the Post:
    Facebook
    Twitter
    LinkedIn